XELOX
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Phase II Trial of Perioperative Adebrelimab Combined With XELOX in Resectable Locally Advanced Gastric/Gastroesophageal Junction Cancer (GC/GEJC) (NCT06506292) | Tianjin Medical University Cancer Institute and Hospital | 2024-07-01 |
Track XELOX automatically
Every clearance here is in the API, with alerts when new ones post.